CARDIOSONIC
Cardiosonic has a special dedication in the diagnosis and treatment of heart and respiratory diseases affecting dogs and cats. Our services include interventionism as valvuloplasties , implantation of Amplatzer for closing the ductus (PDA) or implantation is Tracheal Stent for correction of tracheal collapse . Cardiosonic Veterinary Centers provides service and diagnostic interpretation of ECG and chest X-rays as well as the assessment of echocardiograms performed in your clini
CARDIOSONIC
Industry:
Health Care Health Diagnostics Hospital
Founded:
2009-01-01
Address:
Madrid, Madrid, Spain
Country:
Spain
Website Url:
http://www.cardiosonic.es
Total Employee:
1+
Status:
Closed
Contact:
91.653..99.91
Email Addresses:
[email protected]
Total Funding:
6.1 M USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
REVENTICS
Reventics believes in empowering and partnering with physicians to address the fundamental and longstanding problems of clinical.
Current Advisors List
Current Employees Featured
Founder
Investors List
Shmuel Almagor
Shmuel Almagor investment in Series B - Cardiosonic
More informations about "Cardiosonic"
Cardiosonic Company Profile 2024: Valuation, Funding …
Cardiosonic General Information Description. Developer of proprietary technology in the field of Renal Denervation (RDN) for the treatment of hypertension. The company has developed a high intensity, non-focused therapeutic ultrasound …See details»
Cardiosonic - Crunchbase Company Profile & Funding
Cardiosonic develops pioneering solutions for transluminal high-intensity ultrasound ablation. It has developed a high intensity, non-focused therapeutic ultrasound catheter and control system for remote tissue ablation for the …See details»
CARDIOSONIC LTD Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CARDIOSONIC LTD of TEL AVIV-JAFFA, Central District. Get the latest business insights …See details»
Cardiosonic - VentureRadar
Cardiosonic develops pioneering solutions for transluminal high-intensity ultrasound ablation. The company’s flagship application, the TIVUS high-intensity, directional ultrasound catheter …See details»
Cardiosonic - Israeli Startup | Startup Nation Finder
Apr 22, 2014 Cardiosonic develops solutions for transluminal, high-intensity ultrasound ablation. The company's flagship application, the TIVUS high-intensity, directional ultrasound catheter …See details»
Cardiosonic - Products, Competitors, Financials, Employees ...
Cardiosonic has developed a high intensity, non-focused therapeutic ultrasound catheter and control system for remote tissue ablation for the treatment of hypertension by Renal …See details»
Cardiosonic, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Cardiosonic, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial.See details»
Cardiosonic - Crunchbase
Cardiosonic develops pioneering solutions for transluminal high intensity ultrasound ablation.See details»
Cardiosonic - Funding, Financials, Valuation & Investors
Cardiosonic develops pioneering solutions for transluminal high intensity ultrasound ablation. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... How much …See details»
Cardiosonic - Ultrasonic Energy Solution for Resistant …
Find out more about Cardiosonic's founders and team members at Start-Up Nation Finder!See details»
Cardiosonic Received CE Mark for Its TIVUS Ablative …
Apr 22, 2014 Cardiosonic was founded in 2009 by Shmuel Almagor to develop and commercialize breakthrough ultrasound technology invented by Ariel Sverdlik, now the company's Chief Technology Officer. ContactsSee details»
CARDIOSONIC LTD innovation strategy - GoodIP
CARDIOSONIC LTD has a total of 28 patent applications. Its first patent ever was published in 2011. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO …See details»
SoniVie Receives FDA Breakthrough Device Designation for the …
Dec 9, 2020 Cardiosonic also received a CE Mark for the earlier version of the system. “With our very encouraging clinical data in PAH, and the excellent published data from the TIVUS II …See details»
Cardiosonic - Updates, News, Events, Signals & Triggers
Edit Recent News & Activity Section. Funding Round • Dec 6, 2012. Cardiosonic raised $6,100,000 / Series B from raised $6,100,000 / Series B fromSee details»
Cardiosonics, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Cardiosonics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
FDA Names SoniVie’s TIVUS System a Breakthrough Device for PAH
Sep 11, 2019 Right heart catheterization is commonly used to diagnose PAH as it measures the pressure in the pulmonary arteries and shows the heart’s capacity to pump blood.. SoniVie, …See details»
Cardiosonic - Ultrasonic Energy Solution for Resistant …
Find out more about Cardiosonic's suggested companies. 2023 Israeli High-Tech Annual ReportSee details»
SoniVie Receives FDA Breakthrough Device Designation for the …
Dec 9, 2020 - SoniVie Acquires New Intellectual Property and Other Assets from Cardiosonic Moving TIVUS into New Therapeutic Areas Beyond Pulmonary Hypertension - TEL AVIV, …See details»
SoniVie Receives FDA Breakthrough Device Designation for
Dec 9, 2020 Cardiosonic previously conducted two clinical trials of RDN in patients with resistant hypertension using an earlier version of the TIVUS System, and these trials showed excellent …See details»
cardiosonic - YouTube
Videos de cardiologia, intervencionismos y diagnostico por imagen en veterinaria Vet cardiology videos from SpainSee details»